BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy

April 12, 2013 9:00 AM EDT Send to a Friend
Get Alerts BIIB Hot Sheet
Price: $307.69 +0.91%

Rating Summary:
    21 Buy, 8 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 3 | Down: 17 | New: 2
Trade BIIB Now!
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $246.00 (from $187.00).

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $200.26 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot Upgrades, Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment